By Times Chronicle Staff
Okanagan Clinical Trials (OCT) is seeking volunteers 19 years old or older to participate in an ongoing research study for an investigational vaccine for Respiratory Syncytial Virus (RSV). The study is investigating a potential prevention option for RSV in those who are considered high risk.
Okanagan Clinical Trials is a medical research company located in Kelowna and is currently conducting a study to further evaluate the efficacy of a vaccine for RSV in participants considered high risk, such as those with Chronic Obstructive Pulmonary Disease (COPD), asthma or similar diagnoses.
“Preventing illnesses such as RSV infection and its complications remains a cornerstone in healthcare.” said Dr. Colleen Maytham, Principal Investigator for Okanagan Clinical Trials.
“OCT is proud to participate in a study that hopes to find an effective vaccine for respiratory syncytial virus in adults who are at high risk for complications with the virus,” said Dr. Kim Christie, President of Okanagan Clinical Trials.
Participation in the study will not affect provincial medical coverage and all study-related costs will be paid for by the sponsor, OCT noted, adding that participants are free to leave the study at any time.
To learn more about the study or to volunteer, please visit okanaganclinicaltrials.com or call Okanagan Clinical Trials at 250-862-8141.
